US Animal Vaccine market is expected to reach $5.5 billion in 2027, by growing at a CAGR of 7.7% during the forecast period (2021-2027). The growth of the animal vaccine market is significantly dependent on the adoption of pets in the US household. As the adoption of pets increase, the demand for vaccination services is also expected to rise, thereby, creating opportunities for the growth of animal vaccine market in the US.
To Request a Sample of our Report on US Animal Vaccine Market: https://www.omrglobal.com/request-sample/us-animal-vaccine-market
Veterinary care has a lot to do with species such as dogs and cats. Additionally, dogs and cats are two of the most commonly owned pets of the US household. According to American Veterinary Medical Association (AVMA), 54.3% of cat-owning households and 82.8% of dog-owning households visit the veterinarian at least once a year. Moreover, the total spending on veterinary care & product sales in the US is expected to be nearly around $30.2 billion in 2020. This highlights the fact, that the population in the US, is aware of pet health and the necessary measures that are required to be taken to improve their health. This is expected to create significant opportunities for the growth of the market in the US in future.
North America Holds the Largest Share in the Global Animal Vaccine Market
North America holds a dominant position in the global animal vaccinemarket. It is due to the increased trends of adopting pets as a companion across the region. Besides, animal husbandry has been a substantial factor in increasing the demand for vaccination. Biological research is encouraging the development of disease-specific vaccinations for animal welfare. Further, the presence of major market players including Merck & Co. Inc., Zoetis Inc., and Bayer AG, among others is another major factor contributing to the market growth. These market players claim to generate major revenue from the US.
(Get 15% Discount on Buying this Report)
A full Report of US Animal Vaccine Market is Available at: https://www.omrglobal.com/industry-reports/us-animal-vaccine-market
Scope of the US Animal Vaccine Market
Market Coverage
- Market number available for 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered- By Type and Technology
- Competitive Landscape- Zoetis, Inc., Elanco, Merck & Co., Inc., Novartis International AG and United Vaccines, Inc.
Recent Strategic Initiatives in the US Animal Vaccine Market
- In May 2020, Merck Animal Health, a division of Merck & Co., Inc. signed a definitive agreement with Virbac, animal health product provider company to acquire the US rights to SENTINEL FLAVOR TABS and SENTINEL SPECTRUM Chews in the Companion Animal category. This product acquisition reinforces Merck Animal Health’s commitment to improve the business of the company in the US Companion Animal category.
- In December 2019, Merck Animal Health acquired Vaki, provider of fish farming and wild fish conservation monitoring equipment and real-time video monitoring technology to advance fish health and welfare, from Pentair. With this acquisition, Merck Animal Health had broadened its aquaculture portfolio by expanding into complementary fish farming and conservation areas to generate outcomes with precision farming and fish welfare solutions, which complement its existing portfolio of vaccines and pharmaceuticals.
US Animal Vaccine Market-Segmentation
By Type
- PORCINE VACCINES
- POULTRY VACCINES
- LIVESTOCK VACCINES
- AQUACULTURE VACCINES
By Technology
- LIVE WHOLE VIRUS VACCINES
- KILLED WHOLE VIRUS VACCINES
- SUBUNIT VACCINES
RECOMBINANT VIRUS VACCINES
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
